CDH1 and neoplasm: Compared with the primary tumor, in the metastasis group, the mesenchymal markers (CDH2, VIM, TWIST1, SNAI1, ZEB1) and ferroptosis drivers increased, and the epithelial marker CDH1 and ferroptosis suppressor decreased.